FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311556593> ?p ?o ?g. }

• W4311556593 endingPage "355" @default.
• W4311556593 startingPage "347" @default.
• W4311556593 abstract "To evaluate the effects of sarcopenia and excess visceral fat accumulation on early urinary function after I-125 low-dose-rate brachytherapy for prostate cancer.We retrospectively reviewed consecutive patients who underwent brachytherapy for prostate cancer. Pre-treatment computed tomography was used to measure skeletal muscle index at the L3 level to assess sarcopenia and visceral fat area at the umbilical level. The International Prostate Symptom Score and the University of California Los Angeles Prostate Cancer Index were used to assess quality of life during the 24 months after brachytherapy. Logistic regression analysis was used to examine whether sarcopenia and excess visceral fat accumulation had clinically significant effects on post-treatment quality of life.Among 246 patients, 92 (37.4%) were stratified into the sarcopenia group and 141 (57.3%) into the excess visceral fat accumulation group. The sarcopenia group had significantly lower University of California Los Angeles Prostate Cancer Index urinary function than the non-sarcopenia group 24 months post-brachytherapy. The excess visceral fat accumulation group had significantly poorer International Prostate Symptom Score total, storage, and voiding scores than the non-excess accumulation group 12 months post-brachytherapy. In the multivariate analysis, sarcopenia had a clinically significant adverse effect on the University of California Los Angeles Prostate Cancer Index urinary function at 12 months. Excess visceral fat accumulation had a clinically significant adverse effect on the International Prostate Symptom Score voiding and storage scores at 12 months.Sarcopenia and excess visceral fat accumulation negatively affect urinary function early after I-125 low-dose-rate brachytherapy for prostate cancer." @default.
• W4311556593 created "2022-12-27" @default.
• W4311556593 creator A5001059169 @default.
• W4311556593 creator A5002511250 @default.
• W4311556593 creator A5012943003 @default.
• W4311556593 creator A5013351179 @default.
• W4311556593 creator A5020304167 @default.
• W4311556593 creator A5027670383 @default.
• W4311556593 creator A5030611968 @default.
• W4311556593 creator A5050204003 @default.
• W4311556593 creator A5052330703 @default.
• W4311556593 creator A5064833619 @default.
• W4311556593 creator A5067570661 @default.
• W4311556593 creator A5081573218 @default.
• W4311556593 creator A5086376383 @default.
• W4311556593 creator A5089017308 @default.
• W4311556593 creator A5089553872 @default.
• W4311556593 date "2022-12-15" @default.
• W4311556593 modified "2023-09-26" @default.
• W4311556593 title "Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I‐125 low‐dose‐rate brachytherapy for localized prostate cancer" @default.
• W4311556593 cites W1977733462 @default.
• W4311556593 cites W2016582498 @default.
• W4311556593 cites W2029286797 @default.
• W4311556593 cites W2039708709 @default.
• W4311556593 cites W2040103703 @default.
• W4311556593 cites W2050540953 @default.
• W4311556593 cites W2060586309 @default.
• W4311556593 cites W2110957605 @default.
• W4311556593 cites W2117457995 @default.
• W4311556593 cites W2134725999 @default.
• W4311556593 cites W2154692607 @default.
• W4311556593 cites W2165542105 @default.
• W4311556593 cites W2182145333 @default.
• W4311556593 cites W2286570919 @default.
• W4311556593 cites W2617572194 @default.
• W4311556593 cites W2651727231 @default.
• W4311556593 cites W2889646458 @default.
• W4311556593 cites W2897513125 @default.
• W4311556593 cites W2898523371 @default.
• W4311556593 cites W2901318895 @default.
• W4311556593 cites W2972220523 @default.
• W4311556593 cites W3023263125 @default.
• W4311556593 cites W3030707715 @default.
• W4311556593 cites W3096178296 @default.
• W4311556593 cites W3105207465 @default.
• W4311556593 cites W3117187565 @default.
• W4311556593 cites W3163626740 @default.
• W4311556593 cites W3199256765 @default.
• W4311556593 cites W4235374500 @default.
• W4311556593 doi "https://doi.org/10.1111/iju.15120" @default.
• W4311556593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36520921" @default.
• W4311556593 hasPublicationYear "2022" @default.
• W4311556593 type Work @default.
• W4311556593 citedByCount "0" @default.
• W4311556593 crossrefType "journal-article" @default.
• W4311556593 hasAuthorship W4311556593A5001059169 @default.
• W4311556593 hasAuthorship W4311556593A5002511250 @default.
• W4311556593 hasAuthorship W4311556593A5012943003 @default.
• W4311556593 hasAuthorship W4311556593A5013351179 @default.
• W4311556593 hasAuthorship W4311556593A5020304167 @default.
• W4311556593 hasAuthorship W4311556593A5027670383 @default.
• W4311556593 hasAuthorship W4311556593A5030611968 @default.
• W4311556593 hasAuthorship W4311556593A5050204003 @default.
• W4311556593 hasAuthorship W4311556593A5052330703 @default.
• W4311556593 hasAuthorship W4311556593A5064833619 @default.
• W4311556593 hasAuthorship W4311556593A5067570661 @default.
• W4311556593 hasAuthorship W4311556593A5081573218 @default.
• W4311556593 hasAuthorship W4311556593A5086376383 @default.
• W4311556593 hasAuthorship W4311556593A5089017308 @default.
• W4311556593 hasAuthorship W4311556593A5089553872 @default.
• W4311556593 hasBestOaLocation W43115565931 @default.
• W4311556593 hasConcept C121608353 @default.
• W4311556593 hasConcept C126322002 @default.
• W4311556593 hasConcept C126894567 @default.
• W4311556593 hasConcept C2776214593 @default.
• W4311556593 hasConcept C2776235491 @default.
• W4311556593 hasConcept C2776547966 @default.
• W4311556593 hasConcept C2777416452 @default.
• W4311556593 hasConcept C2779478474 @default.
• W4311556593 hasConcept C2780192828 @default.
• W4311556593 hasConcept C2780221984 @default.
• W4311556593 hasConcept C509974204 @default.
• W4311556593 hasConcept C71924100 @default.
• W4311556593 hasConcept C77411442 @default.
• W4311556593 hasConceptScore W4311556593C121608353 @default.
• W4311556593 hasConceptScore W4311556593C126322002 @default.
• W4311556593 hasConceptScore W4311556593C126894567 @default.
• W4311556593 hasConceptScore W4311556593C2776214593 @default.
• W4311556593 hasConceptScore W4311556593C2776235491 @default.
• W4311556593 hasConceptScore W4311556593C2776547966 @default.
• W4311556593 hasConceptScore W4311556593C2777416452 @default.
• W4311556593 hasConceptScore W4311556593C2779478474 @default.
• W4311556593 hasConceptScore W4311556593C2780192828 @default.
• W4311556593 hasConceptScore W4311556593C2780221984 @default.
• W4311556593 hasConceptScore W4311556593C509974204 @default.
• W4311556593 hasConceptScore W4311556593C71924100 @default.
• W4311556593 hasConceptScore W4311556593C77411442 @default.
• W4311556593 hasIssue "4" @default.

• next